Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,708 | 7,686 | 8,052 | 13,372 | 11,350 |
| Marketable Securities | 37,659 | 49,730 | 61,237 | 62,717 | 64,327 |
| Receivables | 42,155 | 32,959 | 30,333 | 31,110 | 40,803 |
| Inventories | 36,031 | 41,424 | 42,397 | 37,940 | 39,255 |
| TOTAL | $132,054 | $137,997 | $147,602 | $149,437 | $161,402 |
| Non-Current Assets | |||||
| PPE Net | 29,752 | 29,970 | 29,708 | 27,129 | 25,953 |
| Intangibles | 19,940 | 20,177 | 20,415 | 20,652 | 20,890 |
| Other Non-Current Assets | 8,835 | 8,447 | 8,718 | 8,628 | 8,849 |
| TOTAL | $58,527 | $58,594 | $58,841 | $56,409 | $55,692 |
| Total Assets | $190,581 | $196,591 | $206,443 | $205,846 | $217,094 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,726 | 16,103 | 19,959 | 13,223 | 10,522 |
| Accrued Expenses | 21,480 | 20,702 | 18,584 | 17,727 | 23,893 |
| Other current liabilities | 2,429 | 4,103 | 3,357 | 2,230 | 510 |
| TOTAL | $30,635 | $40,908 | $41,900 | $33,180 | $34,925 |
| Non-Current Liabilities | |||||
| Long Term Debt | 55,583 | 53,529 | 53,454 | 53,380 | 53,306 |
| Other Non-Current Liabilities | 17,031 | 12,967 | 13,474 | 13,945 | 15,971 |
| TOTAL | $72,614 | $66,496 | $66,928 | $67,325 | $69,277 |
| Total Liabilities | $103,249 | $107,404 | $108,828 | $100,505 | $104,202 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,591 | 63,718 | 63,173 | 62,905 | 62,619 |
| Common Shares | 64 | 64 | 63 | 63 | 62 |
| Retained earnings | -248,992 | -239,598 | -223,310 | -205,912 | -189,990 |
| Other shareholders' equity | -111 | -25 | 354 | 375 | -184 |
| TOTAL | $87,332 | $89,187 | $97,615 | $105,341 | $112,892 |
| Total Liabilities And Equity | $190,581 | $196,591 | $206,443 | $205,846 | $217,094 |